Literature DB >> 8898128

Tibialis posterior transfer for the correction of foot drop in leprosy. Long-term outcome.

D Soares1.   

Abstract

A comparison was made of the results produced by the circumtibial and interosseous routes of transfer of tibialis posterior for the correction of foot drop due to leprosy neuritis. The findings in 69 feet, of which 63 also had elongation of tendo Achillis, showed that the interosseous route gave a much lower incidence of recurrent inversion deformity of the foot. The results, in terms of improvement in gait and prevention of trophic changes, were satisfactory.

Entities:  

Mesh:

Year:  1996        PMID: 8898128

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  5 in total

1.  CORRELATION BETWEEN QUALITY OF LIFE AND THE CLINICAL RESULTS OF PATIENTS WITH LEPROSY WITH DROP FOOT AFTER TENDON TRANSFER.

Authors:  Jose Carlos Cohen; Natália Coelho Rodrigues; Elifaz de Freitas Cabral; Silvana Teixeira de Miranda; Antonio José Ledo Alves da Cunha; Maria Katia Gomes
Journal:  Acta Ortop Bras       Date:  2022-05-23       Impact factor: 0.683

2.  Early active motion versus immobilization after tendon transfer for foot drop deformity: a randomized clinical trial.

Authors:  Santosh Rath; Ton A R Schreuders; Henk J Stam; Steven E R Hovius; Ruud W Selles
Journal:  Clin Orthop Relat Res       Date:  2010-04-17       Impact factor: 4.176

3.  Tibialis posterior transfer by interosseous route for the correction of foot drop in leprosy.

Authors:  R K Shah
Journal:  Int Orthop       Date:  2009-01-10       Impact factor: 3.075

4.  Tibialis posterior (TP) tendon transfer for foot drop: A single center experience.

Authors:  Pawan Agarwal; Mrityunjay Gupta; Rajeev Kukrele; D Sharma
Journal:  J Clin Orthop Trauma       Date:  2020-03-18

5.  Posterior tibialis tendon transfer via the circumtibial route: a cadaveric limb analysis.

Authors:  Jian Xu; Xiang Geng; Hassan Muhammad; Xin Ma; Xu Wang; Jiazhang Huang; Chao Zhang
Journal:  J Orthop Surg Res       Date:  2014-11-30       Impact factor: 2.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.